WO2011009758A3 - Use of purine and/or a purine derivative and at least one oligonucleotide to influence the natural pigmentation process - Google Patents

Use of purine and/or a purine derivative and at least one oligonucleotide to influence the natural pigmentation process Download PDF

Info

Publication number
WO2011009758A3
WO2011009758A3 PCT/EP2010/060029 EP2010060029W WO2011009758A3 WO 2011009758 A3 WO2011009758 A3 WO 2011009758A3 EP 2010060029 W EP2010060029 W EP 2010060029W WO 2011009758 A3 WO2011009758 A3 WO 2011009758A3
Authority
WO
WIPO (PCT)
Prior art keywords
purine
oligonucleotide
influence
pigmentation process
natural pigmentation
Prior art date
Application number
PCT/EP2010/060029
Other languages
German (de)
French (fr)
Other versions
WO2011009758A2 (en
Inventor
Melanie Giesen
Erik Schulze Zur Wiesche
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Priority to EP10734959A priority Critical patent/EP2473236A2/en
Publication of WO2011009758A2 publication Critical patent/WO2011009758A2/en
Publication of WO2011009758A3 publication Critical patent/WO2011009758A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair

Abstract

The invention relates to the use of a combination of purine and/or a purine derivative and at least of oligonucleotide in order to influence the natural pigmentation process of skin and/or skin appendages.
PCT/EP2010/060029 2009-07-23 2010-07-13 Use of purine and/or a purine derivative and at least one oligonucleotide to influence the natural pigmentation process WO2011009758A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10734959A EP2473236A2 (en) 2009-07-23 2010-07-13 Use of purine and/or a purine derivative and at least one oligonucleotide to influence the natural pigmentation process

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102009027959.8 2009-07-23
DE102009027959 2009-07-23
DE102009044976.0 2009-09-24
DE102009044976A DE102009044976A1 (en) 2009-07-23 2009-09-24 Use of purine and / or a purine derivative and at least one oligonucleotide for influencing the natural pigmentation process

Publications (2)

Publication Number Publication Date
WO2011009758A2 WO2011009758A2 (en) 2011-01-27
WO2011009758A3 true WO2011009758A3 (en) 2012-06-07

Family

ID=43384057

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/060029 WO2011009758A2 (en) 2009-07-23 2010-07-13 Use of purine and/or a purine derivative and at least one oligonucleotide to influence the natural pigmentation process

Country Status (3)

Country Link
EP (1) EP2473236A2 (en)
DE (1) DE102009044976A1 (en)
WO (1) WO2011009758A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009044976A1 (en) 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Use of purine and / or a purine derivative and at least one oligonucleotide for influencing the natural pigmentation process
DE102010043069A1 (en) 2010-10-28 2012-05-03 Henkel Ag & Co. Kgaa Use of purine and / or a purine derivative and at least one amino acid for influencing the natural pigmentation process
DE102011077950A1 (en) 2011-06-22 2012-01-19 Henkel Kgaa Cosmetic, non-therapeutic use of purine and/or its derivative to reduce the formation of reactive oxygen species and for reduction of cellular oxidative stress in the skin and/or its appendages
DE102011079453A1 (en) 2011-07-20 2012-04-12 Henkel Ag & Co. Kgaa Cosmetic, non-therapeutic use of bioquinone compound to increase the effectiveness of substances, which form reactive oxygen species and cellular oxidative stress in skin, and/or reduce skin appendages, and to protect cells of the skin
EP4292581A1 (en) 2022-06-16 2023-12-20 Bella Aurora Labs, S.A. Hair repigmenting composition

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6245527A (en) * 1985-08-21 1987-02-27 Shiseido Co Ltd Preventive and remedy for gray hair
WO1991007945A1 (en) * 1989-11-28 1991-06-13 Lvmh Recherche Utilization of xanthines, optionally incorporated in liposomes in order to help the pigmentation of skin or hair
US5643556A (en) * 1993-07-07 1997-07-01 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
US6267948B1 (en) * 1998-04-06 2001-07-31 Applied Genetics Incorporated Dermatics Dermatological formulations and methods
US20050000040A1 (en) * 2001-10-12 2005-01-06 Beiersdorf Ag Use of one or several substances selected from the group of pyrimidines and purines in cosmetic preparations for coloring hair
US20050208010A1 (en) * 2002-07-10 2005-09-22 L'oreal Genes from Chromosome 3, 5 and 11 involved in premature canities
DE202005001952U1 (en) * 2005-02-06 2006-08-31 Phenion Gmbh & Co. Kg Cosmetic or pharmaceutical preparation, useful for prophylaxis or treatment of epithelial layer tissue, comprises nucleic acids with suitable sequence for forming stem-loop secondary structures
US20070274936A1 (en) * 2003-12-30 2007-11-29 Robin Kurfurst Oligonucleotide and the Use Thereof for Modulating an Isoform C Beta-1 Protein-Kinase in the Form of a Skin Depigmentation Agent
WO2008135169A1 (en) * 2007-04-27 2008-11-13 Henkel Ag & Co. Kgaa Nucleic acid-containing cosmetic and/or pharmaceutical preparations for treating epithelial tissue

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3725030A1 (en) 1987-07-29 1989-02-09 Henkel Kgaa SURFACE ACTIVE HYDROXYSULFONATE
US5136093A (en) 1991-02-06 1992-08-04 Smith Ronald J Quaternized panthenol compounds and their use
DE4413686C2 (en) 1994-04-20 1996-10-24 Henkel Kgaa Cationic sugar surfactants, process for their preparation and their use
DE102009044976A1 (en) 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Use of purine and / or a purine derivative and at least one oligonucleotide for influencing the natural pigmentation process

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6245527A (en) * 1985-08-21 1987-02-27 Shiseido Co Ltd Preventive and remedy for gray hair
WO1991007945A1 (en) * 1989-11-28 1991-06-13 Lvmh Recherche Utilization of xanthines, optionally incorporated in liposomes in order to help the pigmentation of skin or hair
US5643556A (en) * 1993-07-07 1997-07-01 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
US6267948B1 (en) * 1998-04-06 2001-07-31 Applied Genetics Incorporated Dermatics Dermatological formulations and methods
US20050000040A1 (en) * 2001-10-12 2005-01-06 Beiersdorf Ag Use of one or several substances selected from the group of pyrimidines and purines in cosmetic preparations for coloring hair
US20050208010A1 (en) * 2002-07-10 2005-09-22 L'oreal Genes from Chromosome 3, 5 and 11 involved in premature canities
US20070274936A1 (en) * 2003-12-30 2007-11-29 Robin Kurfurst Oligonucleotide and the Use Thereof for Modulating an Isoform C Beta-1 Protein-Kinase in the Form of a Skin Depigmentation Agent
DE202005001952U1 (en) * 2005-02-06 2006-08-31 Phenion Gmbh & Co. Kg Cosmetic or pharmaceutical preparation, useful for prophylaxis or treatment of epithelial layer tissue, comprises nucleic acids with suitable sequence for forming stem-loop secondary structures
WO2008135169A1 (en) * 2007-04-27 2008-11-13 Henkel Ag & Co. Kgaa Nucleic acid-containing cosmetic and/or pharmaceutical preparations for treating epithelial tissue

Also Published As

Publication number Publication date
EP2473236A2 (en) 2012-07-11
WO2011009758A2 (en) 2011-01-27
DE102009044976A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
WO2011009759A3 (en) Use of dihydroquercetin and at least one amino acid to positively influence the natural pigmentation process
ZA201007630B (en) Stable natural color process, products and use thereof
EP2396342A4 (en) Mutant ros expression in human cancer
PL2278952T3 (en) Skin and hand cleansers
HK1170485A1 (en) 1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer 124--3-
ZA201003270B (en) Water-based skin products
EP2429481A4 (en) Method and compositions for improving skin and body appearance
GB0819883D0 (en) Product and uses
WO2011009758A3 (en) Use of purine and/or a purine derivative and at least one oligonucleotide to influence the natural pigmentation process
HK1124779A1 (en) Use of an unsaponifiable extract of plant pulp in the treatment of skin ageing
HK1156968A1 (en) Plant expression constructs comprising and uses thereof
WO2011009763A3 (en) Cosmetic containing purine and/or a purine derivative and sclareol
WO2011035945A3 (en) Use of a combination of carnitine and/or a carnitine derivative with purine and/or a purine derivative for influencing the natural pigmentation process
IL209220A0 (en) Plant extract and its therapeutic use
GB0902537D0 (en) Improvememts in or relating to the creation of curved forms
HK1167359A1 (en) Kit with amusement article, and corresponding process
WO2011009757A3 (en) Use of human beta-defensin to influence the natural pigmentation process
EP2345404A4 (en) Pencil-shaped cosmetic and cosmetic product
WO2011009761A3 (en) Use of carnitine and dihydroquercitin to positively influence the natural pigmentation process
WO2012055580A3 (en) Use of purine and/or a purine derivative and at least one biochinone for influencing the natural pigmentation process
GB0902538D0 (en) Improvvements in or relating to the creation of curved forms
WO2011009756A3 (en) Use of at least one nucleic acid to influence the natural pigmentation process
CA118201S (en) Confectionery product
AU322084S (en) Bread roll
AU322083S (en) Bread roll

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2010734959

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE